SEC 13F Intelligence

CORREVIO PHARMA CORP

CUSIP 22026V105

Correvio Pharma Corp has 30 institutional holders in Filings Flow’s 13F database, together reporting 200 shares worth $78 as of Q1 2023.

Institutional Holders
1
Q1 2023
Reported Value
$78
Ticker
unmapped
private placement or foreign
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 25Q4 ’18Q1 ’19: 29Q1 ’19Q2 ’19: 27Q2 ’19Q3 ’19: 30Q3 ’19Q4 ’19: 21Q4 ’19Q1 ’20: 17Q1 ’20Q1 ’23: 1Q1 ’23filingsflow.com
Total reported value
Q4 ’18: $39MQ4 ’18Q1 ’19: $55MQ1 ’19Q2 ’19: $41MQ2 ’19Q3 ’19: $48MQ3 ’19Q4 ’19: $762,000Q4 ’19Q1 ’20: $690,000Q1 ’20Q1 ’23: $78Q1 ’23filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
American Portfolios Advisors$1.2B AUM0.00%$78200Q1 2023

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.